January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreNovember 01, 2025
Forecasts suggest that the nootropics market will expand from USD 4.98 billion in 2024 to USD 19.53 billion by 2034, with a CAGR of 14.64% during this period. In 2024, North America led the nootropics market, while Asia Pacific is set for the fastest growth. Capsules/tablets dominated by form, but drinks will grow the quickest. Offline channels led...
November 01, 2025
Market insights predict the global cell dissociation industry will increase from USD 406.36 million in 2024 to USD 1451.89 million by 2034, achieving a CAGR of 13.58%. In 2024, North America led the cell dissociation market with a 38% share, while Asia Pacific is set for the fastest growth. Enzymatic dissociation dominated by product, but non-enzym...
November 01, 2025
According to market projections, the preclinical CRO sector is expected to grow from USD 6.25 billion in 2024 to USD 14.34 billion by 2034, reflecting a CAGR of 8.73%. In 2024, North America led the preclinical CRO market with a 48% share, while Asia Pacific is set for the fastest growth through 2034. Toxicology testing dominated by service, while ...
November 01, 2025
Market insights predict the global industrial microbiology industry will increase from USD 12.75 billion in 2024 to USD 24.92 billion by 2034, achieving a CAGR of 6.93%. In 2024, North America led the industrial microbiology market with a 47% share, while Asia Pacific is set for the fastest growth. Reaction consumables dominated by product, but equ...
November 01, 2025
The global cell culture media market, valued at USD 6.9 billion in 2024, is anticipated to reach USD 20.32 billion by 2034, growing at a CAGR of 11.45% over the next decade. In 2024, North America led the global cell culture media market, while Asia-Pacific is set for the fastest growth. Liquid media and serum-free media held the largest shares. Bi...
November 01, 2025
According to market projections, the clinical trial biorepository and archiving solutions sector is expected to grow from USD 4.4 billion in 2024 to USD 9.69 billion by 2034, reflecting a CAGR of 8.21%. In 2024, North America led the clinical trial biorepository and archiving solutions market with a 49% share, while Asia Pacific is set for the fast...
November 01, 2025
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share, while Asia Pacific is set for the fastest growth. Oncology dominated by indication, but rare diseas...
November 01, 2025
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America poised for strong growth. Semi-solid formulations and contract manufacturing dominated, while liquid...
November 01, 2025
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the largest product share and innovators dominating by drug type. Oncology was the top application. Look...
November 01, 2025
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for the fastest growth. Contract manufacturing dominated by service, while contract development is set ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com